AHK-Cu for Health & Longevity

Created on 10/25/2026 – Quick Reference based on Evidence Review created using AI4L + evidence-mcp / Opus 5.5 – Audit

AHK-Cu is a synthetic copper-carrying peptide, applied mostly as a scalp serum and increasingly injected, by people hoping to keep hair, improve skin and support tissue repair. It is untested in people; support comes from human hair follicles kept alive outside the body and animal studies. Main risks: excess copper, contaminated research-use vials, skin irritation. A low-cost, plausible but unproven hair and skin experiment, most uncertain when injected. (Full Review)

Protocol

Topical scalp serum (most common approach)
200–500 ppm, once daily
Per a vendor-linked dosing site; the optimal human dose is unknown
Subcutaneous injection (no established protocol)
250, 350, then 500 mcg daily
Educational chart on a dosing site; no human safety data exist
Time of day
Evening, clean dry scalp
Gives hours of contact; no data favor any time of day
Time to effect
Hair density (humans)
3–6 months
Usual hair-cycle time for visible change; no human timing data exist for AHK-Cu
Hair growth (mice)
14–20 days
Injected AHK-Cu in company patent studies
Wrinkle appearance
8 weeks
In a GHK-Cu trial, not AHK-Cu

Benefits

Contraindications
  • Wilson disease (any stage, including treated)
  • Pregnancy and breastfeeding
  • Active cancer or cancer under treatment
  • Cholestatic liver disease (primary biliary cholangitis, primary sclerosing cholangitis)
  • Known copper contact allergy
Key Interactions
Theoretical (inferred from mechanism)
  • Copper chelators (penicillamine, trientine)
  • Copper supplements and other copper peptides (copper bisglycinate, GHK-Cu)
  • Vitamin C serums and acid exfoliants (L-ascorbic acid, glycolic acid)
  • Topical retinoids (tretinoin, adapalene)
  • Over-the-counter minoxidil and prescription finasteride
  • Angiogenic peptide combinations (BPC-157, TB-500)
  • Microneedling and laser resurfacing

Risk & Side Effects

  • High:
  • Medium:
  • Low: Copper Excess With Injection or Overdosing
  • Speculative: Contaminated or Mislabeled Gray-Market Injectables; Skin Irritation From Unbound Copper; Support of Blood-Vessel Growth in Existing Tumors; Immune Reactions to Injected Peptide

Monitoring

Marker Target Why
Serum copper 70–140 µg/dL Rising values signal copper excess
Ceruloplasmin 20–40 mg/dL Low values suggest Wilson disease
ALT 7–56 U/L Liver safety; elevation stops or changes use
Hair count/density (phototrichogram) No established target; track change from own baseline Expected to change if AHK-Cu works

Cadence: Injected use: laboratory tests at baseline, 8–12 weeks, then every 6 months while use continues; topical use: repeat laboratory tests only if total copper intake is high. Hair photographs and counts at baseline, 3 and 6 months.

Qualitative Assessment

  • Shedding volume during washing and brushing
  • Scalp redness, itching or burning after application
  • Hair thickness, texture and visible scalp coverage in photographs
  • Skin texture and firmness where serum is applied
  • Injection-site redness, swelling or lumps